(Q54501264)

30 May 2018

title

Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines. (English)

1 reference

30 May 2018

author

Ian R. Humphreys

2

1 reference

30 May 2018

Tracy Hussell

3

1 reference

30 May 2018

Gordon Dougan

9

object named as

Gordon Dougan

1 reference

30 May 2018

author name string

Christine Hale

1

1 reference

30 May 2018

Frances Bowe

4

1 reference

30 May 2018

Simon Clare

5

1 reference

30 May 2018

Derek Pickard

6

1 reference

30 May 2018

Andrew Preston

7

1 reference

30 May 2018

Giuseppe Del Giudice

8

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 September 2004

1 reference

30 May 2018

published in

Vaccine

1 reference

30 May 2018

volume

22

1 reference

30 May 2018

issue

27-28

1 reference

30 May 2018

page(s)

3595-3602

1 reference

30 May 2018

Review of the biology of Bordetella pertussis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

The multicenter acellular pertussis trial: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Overview of recent clinical trials of acellular pertussis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Protective surface antigen P69 of Bordetella pertussis: its characterization and very high level expression in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

The vaccination of the newborn infant against pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Immunization and antibody response in the newborn infant. I. Pertussis inoculation within twenty-four hours of birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Neonatal and early life vaccinology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

The mucosal immune system: from fundamental concepts to vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

Immunogenicity of a three-component acellular pertussis vaccine administered at birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

inferred from DOI database lookup

7 January 2021

based on heuristic

Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.039

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.03.039

1 reference

30 May 2018

1 reference

30 May 2018